| ISIN | LU1159236337 | 
|---|---|
| Valor Number | 29080967 | 
| Bloomberg Global ID | |
| Fund Name | State Street Europe Screened Index Equity Fund I | 
| Fund Provider | State Street Investment Management
                                            
    
        Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@statestreet.com Web: www.statestreet.com/im spdrsswitzerland@statestreet.com (ETF Business) | 
| Fund Provider | State Street Investment Management | 
| Representative in Switzerland | State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 | 
| Distributor(s) | State Street Global Advisors | 
| Asset Class | Equities | 
| EFC Category | |
| Distribution Policy | Accumulation | 
| Home Country | Luxembourg | 
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund | 
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund | 
| Investment Strategy *** | The objective of the Fund is to track the performance of the Eurozone equity markets. | 
| Peculiarities | 
| Current Price * | 21.03 EUR | 30.10.2025 | 
|---|---|---|
| Previous Price * | 21.05 EUR | 29.10.2025 | 
| 52 Week High * | 21.06 EUR | 24.10.2025 | 
| 52 Week Low * | 17.02 EUR | 09.04.2025 | 
| NAV * | 21.03 EUR | 30.10.2025 | 
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 664,285,790 | |
| Unit/Share Assets *** | 388,043,140 | |
| Trading Information SIX | ||
| YTD Performance | +14.75% | 31.12.2024 - 30.10.2025
        31.12.2024 30.10.2025 | 
|---|---|---|
| YTD Performance (in CHF) | +13.21% | 31.12.2024 - 30.10.2025
        31.12.2024 30.10.2025 | 
| 1 month | +3.23% | 30.09.2025 - 30.10.2025
        30.09.2025 30.10.2025 | 
| 3 months | +4.78% | 30.07.2025 - 30.10.2025
        30.07.2025 30.10.2025 | 
| 6 months | +9.69% | 30.04.2025 - 30.10.2025
        30.04.2025 30.10.2025 | 
| 1 year | +13.88% | 30.10.2024 - 30.10.2025
        30.10.2024 30.10.2025 | 
| 2 years | +37.58% | 31.10.2023 - 30.10.2025
        31.10.2023 30.10.2025 | 
| 3 years | +49.26% | 31.10.2022 - 30.10.2025
        31.10.2022 30.10.2025 | 
| 5 years | +88.87% | 30.10.2020 - 30.10.2025
        30.10.2020 30.10.2025 | 
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ASML Holding NV | 3.16% | |
|---|---|---|
| SAP SE | 2.30% | |
| HSBC Holdings PLC | 2.02% | |
| Novartis AG Registered Shares | 1.97% | |
| Nestle SA | 1.95% | |
| AstraZeneca PLC | 1.92% | |
| Roche Holding AG | 1.88% | |
| Shell PLC | 1.73% | |
| Siemens AG | 1.69% | |
| Novo Nordisk AS Class B | 1.45% | |
| Last data update | 30.09.2025 | |
| TER *** | 0.25% | 
|---|---|
| TER date *** | 31.12.2023 | 
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.20% | 
| Ongoing Charges *** | 0.25% | 
| SRRI *** | |
| SRRI date *** | 30.09.2025 |